IGF1 and glomerulosclerosis: Another study showed that EA can reduce the levels of iNOS and HO-1/2 and upregulate IGF-1 levels, thus reducing glomerulosclerosis and renal interstitial fibrosis as well as blood pressure in rats with renal failure (54).